Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Microbiology|November 1, 2002
Evaluation of the ICT malaria P.f/P.v and the OptiMal rapid diagnostic tests for malaria in febrile returned travellersE Geoffrey Playford, John Walker
Kidney International|January 16, 2010
Hepatitis B virus infection in hemodialysis populations: progress toward preventionKatherine A Barraclough, E Geoffrey Playford
Scandinavian Journal of Infectious Diseases|March 5, 2014
Parenteral nutrition-associated bloodstream infection in an Australian teaching hospital--an 8-year retrospective study of over 11,000 PN-daysNicola Townell, David McDougall, E Geoffrey Playford
Drugs|April 30, 2010
Management of invasive candidiasis in the intensive care unitE Geoffrey Playford, Jeff Lipman, Tania C Sorrell
The Journal of Antimicrobial Chemotherapy|October 3, 2012
Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, AustraliaDavid A J McDougall, Anthony P Morton, E Geoffrey Playford
Current Opinion in Pharmacology|July 6, 2010
Antifungal therapy in invasive fungal infectionsSharon C-A Chen, E Geoffrey Playford, Tania C Sorrell
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 15, 2017
Ureaplasma urealyticum necrotizing soft tissue infectionIan Gassiep, Letitia Gore, Joanne L Dale, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 18, 2015
Determination of a suitable voriconazole pharmacokinetic model for personalised dosingDavid A J McDougall, Jennifer Martin, E Geoffrey Playford, et al.
The AAPS Journal|June 17, 2016
The Impact of Model-Misspecification on Model Based Personalised DosingDavid A J McDougall, Jennifer Martin, E Geoffrey Playford, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2006
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trialsE Geoffrey Playford, Angela C Webster, Tania C Sorrell, et al.
Pageof 5